Skip to main content
Clinical Trials/JPRN-jRCTs041210149
JPRN-jRCTs041210149
Recruiting
Phase 1

Effect of pig placenta extract (PPE) supplementation on nonalcoholic fatty liver disease - Pilot study

Mutsumi Tsuchishima0 sites10 target enrollmentFebruary 18, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
onalcoholic fatty liver disease
Sponsor
Mutsumi Tsuchishima
Enrollment
10
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mutsumi Tsuchishima

Eligibility Criteria

Inclusion Criteria

  • 1\) Nonalcoholic fatty liver disease
  • 2\) Consent is obtained in writing
  • 3\) BMI: 25kg/m2 or more
  • 4\) Drinking amount: less than 20g/day (600g/month)

Exclusion Criteria

  • 1\) Those who are allergic to pig placenta preparations
  • 2\) Pregnant or nursing mothers
  • 3\) Patients with severe liver disease (decompensated cirrhosis: Child\-Pugh grade C, Hepatocellular carcinoma)
  • 4\) Those who cannot ingest pigs religiously
  • 5\) Patients judged by the principal investigator or sub\-investigator to be inappropriate as research subjects

Outcomes

Primary Outcomes

Not specified

Similar Trials